Literature DB >> 15629315

Posterior vitreous detachment and macular hole formation in myopic foveoschisis.

Nagakazu Matsumura1, Yasushi Ikuno, Yasuo Tano.   

Abstract

PURPOSE: To report two cases of macular hole (MH) associated with myopic foveoschisis (MF).
DESIGN: Interventional case report.
METHODS: Two women presented with metamorphopsia. Preoperative optical coherence tomography (OCT) showed an MH and MF. We performed vitrectomy, internal limiting membrane (ILM) peeling and gas tamponade.
RESULTS: Preoperative OCT examination and intraoperative microscopic observation revealed partial posterior vitreous detachment (PVD) at the posterior retina and vitreous strands adhering to the edge of the MHs. The MF resolved in both patients, but the MHs remained open postoperatively.
CONCLUSIONS: Although the contribution of tangential traction cannot be excluded, the mechanism of MH formation in eyes with MF may be anteroposterior traction via abnormal vitreofoveal adhesion resulting from partial PVD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15629315     DOI: 10.1016/j.ajo.2004.06.064

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis.

Authors:  Su Jin Lim; Yoon Hyung Kwon; Soon Hyun Kim; Yong Sung You; Oh Woong Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

2.  1000 cSt silicone oil vs heavy silicone oil as intraocular tamponade in retinal detachment associated to myopic macular hole.

Authors:  Maurizio Mete; Barbara Parolini; Emilia Maggio; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-16       Impact factor: 3.117

3.  [The primary objective in macular hole surgery. Ultrastructural features of the vitreomacular interface].

Authors:  R G Schumann; M M Schaumberger; M Rohleder; C Haritoglou; A Kampik; A Gandorfer
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 4.  Anatomical and visual outcomes in high myopic macular hole (HM-MH) without retinal detachment: a review.

Authors:  Micol Alkabes; Francesco Pichi; Paolo Nucci; Domenico Massaro; Marco Dutra Medeiros; Borja Corcostegui; Carlos Mateo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-03       Impact factor: 3.117

5.  Assessment of OCT measurements as prognostic factors in myopic macular hole surgery without foveoschisis.

Authors:  Micol Alkabes; Leyla Padilla; Cecilia Salinas; Paolo Nucci; Lucia Vitale; Francesco Pichi; Anniken Burès-Jelstrup; Carlos Mateo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 3.117

6.  The management of macular hole retinal detachment and macular retinoschisis in pathological myopia; a UK collaborative study.

Authors:  Heidi Laviers; Ji-Peng Olivia Li; Anna Grabowska; Stephen J Charles; David Charteris; Richard J Haynes; D Alistair H Laidlaw; David H Steel; David Yorston; Tom H Williamson; Hadi Zambarakji
Journal:  Eye (Lond)       Date:  2018-07-16       Impact factor: 3.775

Review 7.  Myopic foveoschisis: a clinical review.

Authors:  R Gohil; S Sivaprasad; L T Han; R Mathew; G Kiousis; Y Yang
Journal:  Eye (Lond)       Date:  2015-03-06       Impact factor: 3.775

8.  Diagnosis and treatment of myopic traction maculopathy.

Authors:  Ping-Bo Ouyang; Xuan-Chu Duan; Xiao-Hua Zhu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

9.  Radius of curvature changes in spontaneous improvement of foveoschisis in highly myopic eyes.

Authors:  Quan V Hoang; Ching-Lung Chen; Jose Garcia-Arumi; Pamela R Sherwood; Stanley Chang
Journal:  Br J Ophthalmol       Date:  2015-06-30       Impact factor: 4.638

10.  Late recurrence of myopic foveoschisis after successful repair with primary vitrectomy and incomplete membrane peeling.

Authors:  Gonzalo Sepúlveda; Stanley Chang; K Bailey Freund; SungPyo Park; Quan V Hoang
Journal:  Retina       Date:  2014-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.